Ze Zhong
Jiande Branch
Meicheng, 311600, China
Meicheng, 311600, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ultrahigh-throughput screening-assisted in vivo directed evolution for enzyme engineering.
Journal: Biotechnology for biofuels and bioproducts
Published: August 09, 2023
Evaluation of Serum NLRC4 as a Potential Prognostic Biochemical Marker in Humans with Severe Traumatic Brain Injury: A Prospective Cohort Study.
Journal: Risk management and healthcare policy
Published: January 14, 2023
MRTF-A alleviates myocardial ischemia reperfusion injury by inhibiting the inflammatory response and inducing autophagy.
Journal: Molecular and cellular biochemistry
Published: January 24, 2022
miR-8485 alleviates the injury of cardiomyocytes through TP53INP1.
Journal: Journal of biochemical and molecular toxicology
Published: September 06, 2021
Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1-AMPK Pathway.
Journal: Frontiers in physiology
Published: December 22, 2020
Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: March 13, 2019
Anti-apoptotic effects of myocardin-related transcription factor-A on rat cardiomyocytes following hypoxia-induced injury.
Journal: Canadian journal of physiology and pharmacology
Published: February 09, 2016
Impact of mesenchymal stem cells transplantation on myocardial myocardin-related transcription factor-A and bcl-2 expression in rats with experimental myocardial infarction
Journal: Zhonghua xin xue guan bing za zhi
Published: October 01, 2015
Myocardin-related transcription factor-A-overexpressing bone marrow stem cells protect cardiomyocytes and alleviate cardiac damage in a rat model of acute myocardial infarction.
Journal: International journal of molecular medicine
Published: October 24, 2014
Intermedin as a prognostic factor for major adverse cardiovascular events in patients with ST-segment elevation acute myocardial infarction.
Journal: Peptides
Published: May 26, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026